11:41 AM
 | 
Jan 09, 2019
 |  BC Extra  |  Company News

Senior FDA official to head government affairs at CRISPR Therapeutics

John Martin, principal associate commissioner for legislative affairs at FDA, is leaving the agency and joining CRISPR Therapeutics AG (NASDAQ:CRSP) as head of government affairs.

Martin, who joined FDA in 2017, led the agency's negotiation with Congress over...

Read the full 174 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >